Skip to main content

Sally Cheshire is reappointed as HFEA Chair until 2020

We are pleased to announce that Sally Cheshire has been reappointed as our Chair for a further three years from 1 April 2017. 

Commenting on the reappointment, Sally said "I am delighted to have been reappointed as Chair of the HFEA. We have a lot to be proud of, from licensing world firsts like mitochondrial donation and ground-breaking gene editing research, to regulating the day-to-day clinical and emotional journey our patients face as they try to have a much wanted family."

"Our refreshed strategy for 2017-2020 will build on our success and will significantly raise the bar on providing high quality care. We will do that by being clearer with patients about evidence-based treatment, being more transparent about the cost of that treatment, making better use of research and treatment data to improve patient care, and working to improve the quality of commissioning of IVF treatment. We can only do this by continuing to place patients at the centre of what we do."

We are also pleased to announce that existing board member, Margaret Gilmore, will become deputy chair when the current deputy, Professor David Archard, leaves in October 2016. David Archard has served on the HFEA board for 11 years and will be greatly missed. His role will be advertised shortly.

Publication date: 13 April 2017

Review date: 13 April 2019